D. Grasso

A. Ballestrero, P. Pedrazzoli, G. Martinelli, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program

L. Livi, G. Rinaldi, F. Verderame, 2022, Current oncology.

The institution of a Multi‐disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life

P. Pedrazzoli, C. Klersy, P. Politi, 2019, The Breast Journal.

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

C. Tinelli, A. Riccardi, E. Rinaldi, 2001, British Journal of Cancer.

Abstract P5-01-07: Bioitalee - Biomarker analysis on liquid biopsies of patients treated with ribociclib and letrozole as first-line therapy for advanced breast cancer (aBC) (NCT03439046)

V. Adamo, F. Puglisi, G. Arpino, 2020 .

Commentary: “My Husband Affects Me More Than My Cancer”: Reflections on Simultaneous Intimate Partner Violence and Breast Cancer Experience in a 48-Year-Old Woman'

P. Pedrazzoli, P. Politi, V. Martinelli, 2020, Journal of Cancer Treatment and Diagnosis.

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

C. Porta, V. Denaro, M. Papotti, 2011, Journal of cellular physiology.

Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy

C. Tinelli, P. Pedrazzoli, M. Amici, 2016, Cellular Oncology.

Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study

A. Ballestrero, P. Marchetti, D. Generali, 2022, Targeted Oncology.

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

C. Porta, C. Tinelli, L. Cavanna, 2003, European journal of cancer.

RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Eloisa Arbustini, Giuseppe Di Giulio, Alberta Ferrari, 2016, Journal of the National Cancer Institute.

Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.

V. Torri, R. Pedersini, M. Cazzaniga, 2017, Clinical breast cancer.

Single-dose palonosetron and dexamethasone in preventing nausea and vomiting induced by moderately emetogenic chemotherapy in breast and colorectal cancer patients

M. Danova, S. Brugnatelli, D. Grasso, 2011 .

Single-dose palonosetron and dexamethasone in preventing nausea and vomiting induced by moderately emetogenic chemotherapy in breast and colorectal cancer patients

M. Danova, S. Brugnatelli, D. Grasso, 2011, Tumori.

“My Husband Affects Me More Than My Cancer”: Reflections on Simultaneous Intimate Partner Violence and Breast Cancer Experience in a 48-Year-Old Woman

E. Ferraris, A. Ferrari, A. Sgarella, 2019, Journal of Cancer Education.

“My Husband Affects Me More Than My Cancer”: Reflections on Simultaneous Intimate Partner Violence and Breast Cancer Experience in a 48-Year-Old Woman

V. Martinelli, E. Ferraris, A. Ferrari, 2019, Journal of Cancer Education.

Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial

A. Fabi, E. Baldini, D. Grasso, 2022, Breast cancer.